Poultry vaccines are an important component of poultry disease
prevention and control. A vaccine helps to avoid a particular disease
by boosting the bird’s immune system to produce antibodies which
will fight the invading causal organisms. Handling and administration
procedures influence the potency of many vaccines and consequently
the level of immunity the bird develops. Most of the poultry killed
vaccines are developed against viral diseases. A poultry vaccination
program depends on several factors such as type of production, level
of biosecurity, local pattern of disease, status of maternal
immunity, availability of vaccines, and costs and potential losses.
Vaccines are administered through different routes such as in vivo,
intramuscular, subcutaneous, ocular, oral, and nasal. Vaccines can be
applied to five different areas of the egg such as the air cell,
allantoic sac, amniotic fluid, body of embryo, and yolk sac. Hygiene
management, including reduced air circulation, well maintained air
filters, adjustment to weather conditions, and well maintained
hatchery insulation, is important for in vivo vaccination.
Request Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31343
Factors such as government initiatives, rapid growth of poultry
population, and increasing incidence of zoonotic diseases,
technological advancement, and growing demand for poultry derived
food products and poultry vaccination are the key accelerating
factors for the growth of the global poultry vaccines market.
According to Merial Health, by 2020, chicken is projected to overtake
pork as the global animal protein of choice, and the poultry industry
is likely to play an even more crucial role in ensuring food for the
future global populations. In addition, new vaccine innovation,
vaccination programs by leading players, and animal health care
expenditure are factors fueling the growth of the global poultry
vaccines market. However, rising maintenance cost for the storage of
vaccine and increasing adoption of vegetarian food may negatively
affect the market growth.
The global poultry vaccines market has been segmented based on
product type, dosage form, application, end-user, and region. In
terms of product type, the market is classified into modified or
attenuated (live), inactivated (killed), and recombinants. In terms
of dosage form, the market is segmented into liquid vaccine, freeze
dried vaccine, and duct (dry form). In terms of application, the
global market for poultry vaccines is classified into Newcastle
disease, Marek’s disease, infectious bronchitis, infectious bursal
disease, and others. In terms of end-user, the market is segmented
into veterinary hospitals, poultry vaccination centers, and poultry
firms.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=31343
Geographically, the global poultry vaccines market is distributed
over North America, Latin America, Europe, Asia Pacific, and Middle
East & Africa.
North America dominates the global poultry vaccines market due to
factors such as technological advancement, increasing poultry
inventories, growing demand for poultry derived products, and
increasing investment in animal health. According to the National
Chicken Council, the per capita consumption of poultry was 107.6
pounds in 2016 and is expected to reach 109.5 pounds in 2018. Europe
is the second largest market for poultry vaccines globally. Asia
Pacific is expected to expand at a high growth rate due to increasing
poultry production, government vaccination program, and rising
veterinary health care expenditure. These factors are projected to
drive the Asia Pacific market in the near future. According to
ETRetail.com, India is currently the second fastest growing market
for processed meat and poultry globally, accounting for 24% of
processed meat, poultry, and fish product innovations. Indonesia
stands first in this category followed by Vietnam, China, and
Brazil.
Major players operating in this market include Ceva Animal Health
LLC, Zoetis Inc., Eli Lilly and Company, Indovax Private Limited,
Hester Biosciences Limited, S.C ROMVAC COMPANY S.A., Boehringer
Ingelheim Vetmedica, Inc., and Intervet India Pvt. Ltd.
Request for the TOC of the Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=31343
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with
ability to track more than one million high growth niche products are
aligned with your aims. The detailed and proprietary statistical
models used by our analysts offer insights for making right decision
in the shortest span of time. For organizations that require specific
but comprehensive information we offer customized solutions through
adhoc reports. These requests are delivered with the perfect
combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems
with right methodology of research is the key to help enterprises
reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment